Back

Cardioprotective effects of prophylactic ACE Inhibitors in anthracycline-based chemotherapy: a systematic review and meta-analysis

4 April 2025 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular protection in patients with cancer Cardio-Oncology EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mr Davide Pizzi

International Medical School, Milano (Italy)

2 More presentations in this session

Presentation thumbnail
PSA - a potential biomarker for the intersection of screening for cardiovascular disease and cancer
Ms E. Unger (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Semaglutide and dapagliflozin synergistically prevent cancer therapy-related cardiac dysfunction in hyperglycemic conditions
Doctor V. Quagliariello (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular protection in patients with cancer

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 13:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources